MOH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Molina Healthcare Inc (MOH) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are neutral, options data shows mixed sentiment, and insider selling is significantly high. While analysts have raised price targets, the ratings remain mixed, and there are no recent positive news catalysts or strong proprietary trading signals to justify immediate action. Holding off for now is advisable.
The MACD histogram is slightly positive at 0.0383, but contracting, indicating weakening momentum. RSI is neutral at 50.071, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading below the pivot level of 197.539, with key support at 191.828 and resistance at 203.25. The technical outlook does not strongly favor a buy.
Analysts have raised price targets recently, with some firms like BofA upgrading the stock to Buy and projecting a price target of $250 due to improving Medicaid margins. Bullish moving averages also suggest long-term potential.
Insider selling has surged by 4513.69% over the last month, indicating a lack of confidence from company insiders. No recent news or event-driven catalysts. Hedge funds are neutral, and Congress trading data shows no activity. The stock has a 50% chance of declining 2.91% in the next week.
No financial data provided for analysis. Unable to assess the company's latest quarter performance.
Analyst ratings are mixed. While some firms like BofA and Barclays have raised price targets significantly, others like Morgan Stanley and Truist maintain cautious or neutral stances. The consensus does not strongly favor an immediate buy.
